Colorectal Cancer Screening Age Recommendations
Colorectal cancer screening should begin at age 45 for average-risk individuals, as recommended by the US Preventive Services Task Force (USPSTF) and the American Cancer Society (ACS). 1
Screening Recommendations by Age Group
Ages 45-49
- The US Multi-Society Task Force on Colorectal Cancer suggests offering CRC screening to all average-risk individuals ages 45-49 (weak recommendation; low-quality evidence) 2
- This represents a change from previous recommendations that started screening at age 50, reflecting increasing rates of colorectal cancer in younger adults 1
Ages 50-75
- For average-risk individuals who have not initiated screening before age 50, screening is strongly recommended beginning at age 50 (strong recommendation, high-quality evidence) 2
- Screening should continue through age 75 for those in good health with life expectancy greater than 10 years 1
Ages 76-85
- Screening decisions should be individualized based on:
- Prior screening history
- Overall health status
- Life expectancy
- Patient preferences 1
- Persons without prior screening should be considered for screening up to age 85, depending on age and comorbidities (weak recommendation, low-quality evidence) 2
Age >85
- Screening should be discontinued as the benefits are outweighed by the risks 1
Special Populations
African Americans
- Current guidelines recommend screening beginning at age 45 for all populations, including African Americans 1
- This represents a change from older guidelines that had recommended earlier screening specifically for African Americans 3
Higher-Risk Individuals
- Those with a first-degree relative diagnosed with CRC or advanced adenoma before age 60 should begin screening at age 40 or 10 years before the youngest affected relative's diagnosis (whichever is earlier) 1
- Screening should be performed by colonoscopy every 5 years for these higher-risk individuals 1
Recommended Screening Modalities
Tier 1 (Preferred Options)
- Colonoscopy every 10 years (strong recommendation; moderate-quality evidence) 2, 1
- Annual fecal immunochemical test (FIT) (strong recommendation; moderate-quality evidence) 2, 1
Tier 2 Options
- CT colonography every 5 years (strong recommendation, low-quality evidence) 2, 1
- FIT-fecal DNA test every 3 years (strong recommendation, low-quality evidence) 2, 1
- Flexible sigmoidoscopy every 5-10 years (strong recommendation, high-quality evidence) 2, 1
Tier 3 Option
Important Clinical Considerations
- All positive results on non-colonoscopy screening tests must be followed up with timely colonoscopy 1
- Patients with symptoms such as colorectal bleeding should undergo diagnostic colonoscopy regardless of age or screening status 1
- Consider stopping screening when persons up to date with screening and negative prior screening tests (particularly colonoscopy) reach age 75 or have <10 years of life expectancy 2
- The predominance of right-sided procedures supports the use of full colonoscopy as the primary screening method 4
Pitfalls to Avoid
- Failing to recognize that colorectal cancer incidence is rising in persons under age 50, requiring thorough diagnostic evaluation of young persons with suspected colorectal bleeding 5
- Neglecting to follow up positive non-colonoscopy screening tests with colonoscopy
- Not considering family history when determining screening age and intervals
- Continuing screening in very elderly patients or those with limited life expectancy where risks may outweigh benefits